Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / M••• C••••

P•••• Acquires M•••, a Clinically-Studied Portfolio of Muscle Health Products that Support Muscle Preservation, Injury Recovery, and Healthy Aging for Pets

Add-on acquisitionclosedadd-onannounced Jul 29, 2026closed Jul 29, 2026Fact
What happened
Platform
P••••• I•••add-on basis: P•••• is a portfolio company of B•••• Group, a private investment firm that specializes in building distinctive consumer brands.
Control
Control
Share acquired
unknown
Industry
consumer / pet
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
9 named
Buy side
  • P•••• is a portfolio company of B•••• Group, a private investment firm that specializes in building distinctive consumer brands.
  • P•••• is a portfolio company of B•••• Group, a private investment firm that specializes in building distinctive consumer brands.
Advisory side
  • L•••••• I••••••••• L••Buy-side adviserconfirmed
    L•••••• International served as financial advisor, and D•••• P••• served as legal counsel to P•••• and B•••• Group.
  • D•••• G•••••Legal adviserconfirmed
    C•••• V• P••••••• served as financial advisor, and D•••• G••••• served as legal counsel to M•••.
  • D•••• P•••Legal adviserconfirmed
    L•••••• International served as financial advisor, and D•••• P••• served as legal counsel to P•••• and B•••• Group.
  • C•••• V• P•••••••Sell-side adviserconfirmed
    C•••• V• P••••••• served as financial advisor, and D•••• G••••• served as legal counsel to M•••.
Side not stated
  • "We're very excited to partner with P••••," said J•• M•••••••, CEO of M••• C•••• "P••••'s distribution reach, brand-building expertise, and operating discipline are exactly what M••• and Fortetropin® need to realize their full potential and reach more pet owners globally."
  • "Pet parents are increasingly looking for solutions that support their pets' mobility, recovery, and long-term vitality — not just treatment after a problem arises," said C•••••• P•••, Chief Executive Officer of P••••.
  • P••••• I••• ("P••••"), a leading pet health and wellness company and portfolio company of B•••• Group, today announced it has closed the acquisition of M••• Corp ("M•••") and its Fortetropin®-based product portfolio of muscle health products for the animal health category, spanning both consumer-fac
Evidence
P••••• I••• ("P••••"), a leading pet health and wellness company and portfolio company of B•••• Group, today announced it has closed the acquisition of M••• Corp ("M•••") and its Fortetropin®-based product portfolio of muscle health products for the animal health category, spanning both consumer-facing supplements and veterinary exclusive formulations.